Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular genetics of the debrisoquin-sparteine polymorphism.

Clinical pharmacology and therapeutics - 1 Sept 1991

Gonzalez F J, Meyer U A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Chromosome Mapping
Share to Cytochrome P-450 Enzyme System
Share to Debrisoquin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Polymorphism, Restriction Fragment Length

Share to Sparteine

Source

Identifiers

PMID: 1680592
DOI: 10.1038/clpt.1991.131

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular genetics of the debrisoquin-sparteine polymorphism.PMID 1680592Read ↗

[The genetically determined polymorphism of metabolic oxidation of the sparteine-debrisoquin type].Semantic proximity Read ↗

Interpretation of a simple PCR analysis of the CYP2D6(A) and CYP2D6(B) null alleles associated with the debrisoquine/sparteine genetic polymorphism.Semantic proximity Read ↗

Polymorphism of debrisoquine oxidation in New Zealand Caucasians.Semantic proximity Read ↗

[Genetic polymorphism in human drug metabolism].Semantic proximity Read ↗

Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.Semantic proximity Read ↗

Molecular mechanisms of genetic polymorphisms of drug metabolism.Semantic proximity Read ↗

Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine type.Semantic proximity Read ↗

Debrisoquine and N-acetylation polymorphism in Syria.Semantic proximity Read ↗

Dinucleotide repeat polymorphism at the debrisoquine 4-hydroxylase (CYP2D) locus.Semantic proximity Read ↗

The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.Semantic proximity Read ↗

New allelic arrangement CYP2D6*36 x 2 found in a Japanese poor metabolizer of debrisoquine.Semantic proximity Read ↗

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.